A narrative review of illegal online pharmacies and contemporary issues with restricting FDA-approved medication access

被引:0
|
作者
Jillani, Zarnab [1 ]
Reinhard, Lauren [1 ]
Hertig, John [1 ]
机构
[1] Butler Univ, 4600 Sunset Ave, Indianapolis, IN 46208 USA
来源
关键词
Abortifacient restriction; illegal online pharmacies; substandard and falsified medications; counterfeit drugs; online purchasing; Roe versus Wade; access to medications for abortion;
D O I
10.1177/27550834231220512
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The rapid growth of technology has transformed the way the public purchases many products, including medications. Online medication purchasing has become a convenient and confidential route for patients to access healthcare without leaving their homes. Online pharmacies have many benefits but also present an increased risk for patient harm caused by unintentionally purchasing from illegal online pharmacies. Illegal online pharmacies are those that operate online without the requisite valid licenses or supply drugs not approved by the Food and Drug Administration (FDA). As obtaining certain medications has become restricted, either due to policy or drug shortages, more patients are relying on services provided by Internet pharmacies. The overturning of Roe versus Wade has caused an emerging drug restriction that may coerce the public to turn to Internet pharmacies for purchasing medications. A narrative review was conducted to analyze both the past and present effects of medications sold by illegal online pharmacies to help recognize the implications of restricting access to FDA-approved medications. Several large science and health literature databases were searched to find relevant references. Resulting resources, which referenced the connection between restricting access to FDA-approved medications and the increase in illegal online sales, were included in this review. The information evaluated in this article will help inform healthcare providers and policymakers of the inadvertent effects of restricting access to FDA-approved medications. A Narrative Review of Illegal Online Pharmacies and Contemporary Issues with Restricting FDA-Approved Medication Access
引用
收藏
页数:9
相关论文
共 7 条
  • [1] A critical review of FDA-approved medication guides
    Wolf, Michael S.
    Davis, Terry C.
    Shrank, William H.
    Neuberger, Marolee
    Parker, Ruth M.
    [J]. PATIENT EDUCATION AND COUNSELING, 2006, 62 (03) : 316 - 322
  • [2] ACCESS TO CARE: ARE HCG AND FSH AVAILABLE FROM FDA-APPROVED PHARMACIES FOR MEN WITH HYPOGONADISM AND INFERTILITY?
    Borgert, B.
    Bacchu, M.
    Hernandez, A.
    Potts, S.
    Campbell, K.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2023, 20
  • [3] EVALUATION OF REGULATORY PARTICULARS AND CMC REVIEW ISSUES FOR FDA-APPROVED CELL THERAPY PRODUCTS
    McCord, A.
    [J]. CYTOTHERAPY, 2024, 26 (06) : S118 - S118
  • [4] A narrative review of the efficacy and safety FDA-approved antibody-drug conjugates in older patients
    Hsu, Robert
    Nieva, Jorge J.
    [J]. AME MEDICAL JOURNAL, 2024, 9
  • [5] Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review
    Lingaratnam, Senthil
    Hussainy, Safeera Yasmeen
    Murphy, Alexandra
    Perrin, Cale
    Samuvel, Melbin
    Mehrvarz, Elahe
    Lim, Chiao Xin
    Zalcberg, John
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2024, 17 (01)
  • [6] Comparison of FDA-Approved Electrical Neuromodulation Techniques for Focal Neuropathic Pain: A Narrative Review of DRG, HF10, and Burst Neuromodulation
    Podgorski, Edward, III
    Mascaro, Pedro
    Patin, Dennis
    [J]. PAIN PHYSICIAN, 2021, 24 (04) : E407 - E423
  • [7] FDA-Approved Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) Inhibitors for Managing Rheumatoid Arthritis: A Narrative Review of the Literature
    Potlabathini, Tejaswini
    Pothacamuri, Mounica A.
    Bandi, Venkata Varshitha
    Anjum, Mahnoor
    Shah, Parmendra
    Molina, M.
    Dutta, Nilashis
    Adzhymuratov, Oleksandr
    Mathew, Midhun
    Sadu, Vatsalya
    Zahid, Shiza A.
    Lingamgunta, Harini
    Sahotra, Monika
    Nasiri, Syed Muhammad Zain Jamil
    Daguipa, Christine Dawn M.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)